# Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)

> **NCT00093262** · PHASE3 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 206 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** clevidipine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00093262
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093262, "Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00093262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*